On January 11, 2023 Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, reported that Chairman and CEO Leonard Mazur will present at the Sidoti Micro-Cap Virtual Conference on January 18, 2023 (Press release, Citius Pharmaceuticals, JAN 11, 2023, View Source [SID1234626188]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conference Details:
Date:

Wednesday, January 18, 2023

Time:

10:45 AM ET

Location:

Virtual

Live presentation:

Viewers must register for the conference to view the live presentation.

1×1 meetings:

Investors may request meetings by contacting their Sidoti representative or Citius Investor Relations.